Visitor Monitoring Drug History: INTEGRILIN
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: INTEGRILIN
FDA Application No: (NDA) 020718
Active Ingredient(s): EPTIFIBATIDE
Company: SCHERING
 
Label History
 
View the label approved on October 14, 2005 for INTEGRILIN, (NDA) 020718


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
10/12/2005 025Labeling Revision Letter
Label 
7/15/2004 022Labeling Revision Letter 
6/16/2003 017Efficacy Supplement with Clinical Data to Support Letter
Label 
2/14/2002 016Manufacturing Change or Addition  
1/10/2002 015Control Supplement  
7/26/2001 014Manufacturing Change or Addition  
6/8/2001 013Labeling Revision Letter
Label
Review 
7/3/2001 011Manufacturing Change or Addition  
6/8/2001 010New Dosage Regimen Letter
Label
Review 
5/31/2000 009Control Supplement  
6/26/2000 008Manufacturing Change or Addition  
3/3/2000 007Control Supplement  
12/3/1999 006Manufacturing Change or Addition  
4/16/1999 005Manufacturing Change or Addition  
7/21/1999 004Control Supplement  
7/21/1999 003Labeling Revision  
9/20/1999 002Efficacy Supplement with Clinical Data to Support Letter
Label
Review 
9/11/1998 001Labeling Revision  
5/18/1998 000Approval Letter
Label
Review
Consumer Information Sheet 
 
©2019 Drugs That Causes a False Positive on a Drug Test